DIA423.11-3.17 -0.74%
SPX5,982.72-50.39 -0.84%
IXIC19,521.09-180.12 -0.91%

This Sarepta Therapeutics Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

Benzinga·06/16/2025 13:47:02
Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Jefferies analyst Philip Ng downgraded Packaging Corporation of America (NYSE:PKG) from Buy to Hold and lowered the price target from $245 to $205. Packaging Corp of America shares closed at $188.56 on Friday. See how other analysts view this stock.
  • HC Wainwright & Co. analyst Mitchell Kapoor downgraded the rating for Sarepta Therapeutics, Inc. (NASDAQ:SRPT) from Neutral to Sell and lowered the price target from $40 to $10. Sarepta Therapeutics shares closed at $36.18 on Friday. See how other analysts view this stock.
  • JMP Securities analyst Nicholas Jones downgraded the rating for Angi Inc. (NASDAQ:ANGI) from Market Outperform to Market Perform. Angi shares closed at $15.44 on Friday. See how other analysts view this stock.
  • Maxim Group analyst Allen Klee downgraded Ohmyhome Limited (NASDAQ:OMH) from Buy to Hold. Ohmyhome shares closed at $1.42 on Friday. See how other analysts view this stock.
  • Baird analyst Rob Oliver downgraded PROS Holdings, Inc. (NYSE:PRO) from Outperform to Neutral and lowered the price target from $27 to $18. Pros Holdings shares closed at $15.78 on Friday. See how other analysts view this stock.

Considering buying SRPT stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.